Factors Associated with Hepatitis C Antibody Positivity in Korean Adults: A Cross-Sectional Study Based on 2013–2018 Korea National Health and Nutrition Examination Survey
Abstract
:1. Introduction
2. Methods
2.1. Subjects
2.2. Variables
2.2.1. Dependent Variable
2.2.2. Independent Variable
2.3. Statistical Analysis
3. Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- World Health Organization. Global Hepatitis Report 2017; World Health Organization: Geneva, Switzerland, 2017; Available online: https://www.who.int/hepatitis/publications/global-hepatitis-report2017/en/ (accessed on 10 August 2020).
- Lavanchy, D. Evolving epidemiology of hepatitis C virus. Clin. Microbiol. Infect. 2011, 17, 107–115. [Google Scholar] [CrossRef] [Green Version]
- Jeong, S.-H. Epidemiology of Hepatitis C Virus Infection in Korea. Korean J. Med. 2015, 88, 630–634. [Google Scholar] [CrossRef]
- Hajarizadeh, B.; Grebely, J.; Dore, G.J. Epidemiology and natural history of HCV infection. Nat. Rev. Gastroenterol. Hepatol. 2013, 10, 553–562. [Google Scholar] [CrossRef] [PubMed]
- Ashkani-Esfahani, S.; Alavian, S.M.; Salehi-Marzijarani, M. Prevalence of hepatitis C virus infection among hemodialysis patients in the Middle-East: A systematic review and meta-analysis. World J. Gastroenterol. 2017, 23, 151–166. [Google Scholar] [CrossRef] [PubMed]
- Hofmeister, M.G.; Rosenthal, E.M.; Barker, L.K.; Rosenberg, E.S.; Barranco, M.A.; Hall, E.W.; Edlin, B.R.; Mermin, J.; Ward, J.W.; Ryerson, A.B. Estimating Prevalence of Hepatitis C Virus Infection in the United States, 2013–2016. Hepatology 2019, 69, 1020–1031. [Google Scholar] [CrossRef]
- The Korean Association for the Study of the Liver (KASL). KASL clinical practice guidelines: Management of hepatitis C. Clin. Mol. Hepatol. 2016, 22, 76–139. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kim, J.Y.; Cho, J.; Hwang, S.H.; Kil, H.; Bae, S.H.; Kim, Y.S.; Lee, H.C.; Jeong, S.-H. Behavioral and Healthcare-Associated Risk Factors for Chronic Hepatitis C Virus Infection in Korea. J. Korean Med. Sci. 2012, 27, 1371–1377. [Google Scholar] [CrossRef] [Green Version]
- Pereira, L.M.; Martelli, C.M.; Moreira, R.C.; Merchan-Hamman, E.; Stein, A.T.; A Cardoso, R.M.; Figueiredo, G.M.; Montarroyos, U.R.; Braga, C.; Turchi, M.D.; et al. Prevalence and risk factors of Hepatitis C virus infection in Brazil, 2005 through 2009: A cross-sectional study. BMC. Infect. Dis. 2013, 13, 60. [Google Scholar] [CrossRef]
- Chae, H.B. Epidemiologic Study for the Risk Factors of HCV Transmission. Korean Disease Control and Prevention Agency, Online. 2012. Available online: http://www.cdc.go.kr/board.es?mid=a40801000000&bid=0050&act=view&list_no=20873 (accessed on 10 August 2020).
- Kim, S.N.; Ahn, Y.S.; Park, H.J.; Lee, H.M. Hepatitis C awareness survey results and self checklist development. Wkly Health Illn. 2020, 13, 18–26. Available online: http://kdca.go.kr/board/board.es?mid=a20602010000&bid=0034&act=view&list_no=365632 (accessed on 10 August 2020).
- Kim, J.I. Hepatitis C National Examination System Legislative Example. Latest Foreign Legislative Information, 113 (2019.12.10), 1–6. National Assembly Library. Available online: https://nanet.go.kr/main.do (accessed on 10 August 2020).
- Younossi, Z.M.; Stepanova, M.; Nader, F.; Younossi, Z.; Elsheikh, E. Associations of chronic hepatitis C with metabolic and cardiac outcomes. Aliment. Pharmacol. Ther. 2013, 37, 647–652. [Google Scholar] [CrossRef] [Green Version]
- Mirminachi, B.; Mohammadi, Z.; Merat, S.; Neishabouri, A.; Sharifi, A.H.; Alavian, S.H.; Poustchi, H.; Malekzadeh, R. Update on the Prevalence of Hepatitis C Virus Infection Among Iranian General Population: A Systematic Review and Meta-Analysis. Zahedan. J. Res. Med. Sci. 2017, 17. [Google Scholar] [CrossRef]
- Meffre, C.; Le Strat, Y.; Delarocque-Astagneau, E.; Dubois, F.; Antona, D.; Lemasson, J.-M.; Warszawski, J.; Steinmetz, J.; Coste, D.; Meyer, J.-F.; et al. Prevalence of hepatitis B and hepatitis C virus infections in France in 2004: Social factors are important predictors after adjusting for known risk factors. J. Med. Virol. 2010, 82, 546–555. [Google Scholar] [CrossRef]
- Umumararungu, E.; Ntaganda, F.; Kagira, J.; Maina, N. Prevalence of Hepatitis C Virus Infection and Its Risk Factors among Patients Attending Rwanda Military Hospital, Rwanda. Bio. Med. Res. Int. 2017, 2017, 1–7. [Google Scholar] [CrossRef] [PubMed]
- Ahn, H.R.; Jeong, H.J. Association between Socioeconomic status and hepatitis C prevalence among community-dwelling adults. J. Korean Public Health Nur. 2017, 31, 234–243. [Google Scholar] [CrossRef]
- Präg, P.; Mills, M.C.; Wittek, R. Subjective socioeconomic status and health in cross-national comparison. Soc. Sci. Med. 2016, 149, 84–92. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Huttunen, R.; Heikkinen, T.; Syrjänen, J. Smoking and the outcome of infection. J. Intern. Med. 2010, 26, 258–269. [Google Scholar] [CrossRef]
- Corpechot, C.; Gaouar, F.; Chrétien, Y.; Johanet, C.; Chazouilleres, O.; Poupon, R. Smoking as an independent risk factor of liver fibrosis in primary biliary cirrhosis. J. Hepatol. 2012, 56, 218–224. [Google Scholar] [CrossRef]
- Kai, K.; Komukai, S.; Koga, H.; Yamaji, K.; Ide, T.; Kawaguchi, A.; Aishima, S.; Noshiro, H. Correlation between smoking habit and surgical outcomes on viral-associated hepatocellular carcinomas. World J. Gastroenterol. 2018, 24, 58–68. [Google Scholar] [CrossRef]
- Chuang, S.-C.; Lee, Y.-C.A.; Hashibe, M.; Dai, M.; Zheng, T.; Boffetta, P. Interaction between cigarette smoking and hepatitis B and C virus infection on the risk of liver cancer: A meta-analysis. Cancer Epidemiol. Biomark. Prev. 2010, 19, 1261–1268. [Google Scholar] [CrossRef] [Green Version]
- Szabo, G.; Mandrekar, P. Focus on: Alcohol and the liver. Alcohol Res. Health 2010, 33, 87–96. [Google Scholar]
- Adinolfi, L.E.; Restivo, L.; Guerrera, B.; Sellitto, A.; Ciervo, A.; Iuliano, N.; Rinaldi, L.; Santoro, A.; Vigni, G.L.; Marrone, A. Chronic HCV infection is a risk factor of ischemic stroke. Atherosclerosis 2013, 231, 22–26. [Google Scholar] [CrossRef] [PubMed]
- Cooper, C.L.; Galanakis, C.; Donelle, J.; Kwong, J.; Boyd, R.; Boucher, L.; Kendall, C.E. HCV-infected individuals have higher prevalence of comorbidity and multimorbidity: A retrospective cohort study. BMC Infect. Dis. 2019, 19, 1–15. [Google Scholar] [CrossRef] [Green Version]
Variables | Categories | Total (n = 32,942) | HCV Antibody Positive | χ2 (p) | |
---|---|---|---|---|---|
No (n = 32,660) | Yes (n = 282) | ||||
n * (%) † | n * (%) † | n * (%) † | |||
Gender | Male | 14,450 (50.3) | 14,329 (50.3) | 121 (48.6) | 0.287 (0.505) |
Female | 18,492 (49.7) | 18,331 (49.7) | 161 (51.4) | ||
Age | 20s | 3653 (16.9) | 3644 (17.0) | 9 (5.4) | 97.437 (p < 0.001) |
30s | 5412 (19.1) | 5399 (19.1) | 13 (6.7) | ||
40s | 6267 (21.4) | 6234 (21.4) | 33 (16.5) | ||
50s | 6578 (20.3) | 6516 (20.3) | 62 (27.6) | ||
≥60s | 11,032 (22.3) | 10,867 (22.1) | 165 (43.8) | ||
House income | Low | 6118 (15.0) | 6026 (14.9) | 92 (29.3) | 34.887 (p < 0.001) |
Middle | 17,167 (53.9) | 17,027 (54.0) | 140 (49.5) | ||
High | 9497 (31.1) | 9448 (31.2) | 49 (21.1) | ||
Education | ≤Elementary | 6601 (15.2) | 6492 (15.0) | 109 (34.9) | 71.178 (p < 0.001) |
Middle | 3215 (8.9) | 3175 (8.9) | 40 (14.3) | ||
High school | 10,074 (36.0) | 10,009 (36.0) | 65 (29.5) | ||
≥College | 11,013 (39.9) | 10,968 (40.1) | 45 (21.4) | ||
Working status | No | 12,066 (35.1) | 11,932 (35.0) | 134 (46.1) | 10.969 (p < 0.001) |
Yes | 18,803 (64.9) | 18,678 (65.0) | 125 (53.9) |
Variables | Categories | Total (n = 32,942) | HCV Antibody Positive | ||
---|---|---|---|---|---|
No (n = 32,660) | Yes (n = 282) | χ2 (p) | |||
n * (%) † | n * (%) † | n * (%) † | |||
Stress perception | Low feeling | 23,711 (72.7) | 23,509 (72.7) | 202 (74.0) | 0.201 (0.574) |
High feeling | 8240 (27.3) | 8170 (27.3) | 70 (26.0) | ||
Self-rated health status | Bad | 5971 (17.3) | 5878 (17.2) | 93 (33.8) | 41.730 (p < 0.001) |
Moderate | 16,095 (51.8) | 15,968 (51.9) | 127 (48.6) | ||
Good | 9009 (30.8) | 8967 (30.9) | 42 (17.6) | ||
Smoking status | Non smoker | 19,189 (56.1) | 19,038 (56.2) | 151 (52.0) | 1.923 (0.287) |
Ex-smoker | 6714 (21.1) | 6646 (21.1) | 68 (21.8) | ||
smoker | 6054 (22.8) | 6002 (22.8) | 52 (26.3) | ||
Past smoking period(years) | <1 | 5517 (16.3) | 5456 (16.3) | 61 (19.5) | 4.732 (0.010) |
1–10 | 1096 (4.0) | 1089 (4.0) | 7 (1.9) | ||
≥10 | 25,932 (79.7) | 25,722 (79.7) | 210 (78.6) | ||
Alcohol consumption | Low risk drinking | 17,281 (69.9) | 17,157 (69.9) | 124 (75.6) | 2.251 (0.079) |
High risk drinking | 5919 (30.1) | 5883 (30.1) | 36 (24.4) | ||
Binge drinking | None | 9195 (34.3) | 9133 (34.3) | 62 (32.1) | 1.291 (0.786) |
<1/month | 4612 (20.9) | 4577 (20.9) | 35 (23.3) | ||
1/month | 3659 (17.7) | 3636 (17.7) | 23 (18.5) | ||
1/week | 4182 (19.9) | 4156 (19.9) | 26 (17.7) | ||
Almost everyday | 1542 (7.3) | 1528 (7.3) | 14 (8.5) | ||
BMI | Low | 1221 (4.1) | 1212 (4.1) | 9 (3.1) | 1.913 (0.245) |
Normal | 20,374 (61.6) | 20,206 (61.7) | 168 (58.7) | ||
Obesity | 11,273 (34.3) | 11,169 (34.3) | 104 (38.2) | ||
CVA dx. | No | 30,345 (98.3) | 30,097 (98.3) | 248 (94.5) | 11.436 (p < 0.001) |
Yes | 726 (1.7) | 712 (1.7) | 14 (5.5) | ||
MI or Angina dx. | No | 30,799 (99.3) | 29,948 (98.0) | 254 (98.3) | 0.089 (0.417) |
Yes | 262 (0.7) | 851 (2.0) | 8 (1.7) | ||
Liver cancer dx. | No | 31,013 (99.7) | 30,755 (99.7) | 258 (95.8) | 3.862 (p < 0.001) |
Yes | 40 (0.3) | 94 (0.3) | 3 (4.2) | ||
Cirrhosis dx. | No | 30,943 (99.7) | 30,694 (99.7) | 249 (95.4) | 32.665 (p < 0.001) |
Yes | 106 (0.3) | 94 (0.3) | 12 (4.6) | ||
Hepatitis B dx. | No | 30,636 (98.7) | 30,383 (98.7) | 253 (97.6) | 1.795 (0.038) |
Yes | 413 (1.3) | 405 (1.3) | 8 (2.4) | ||
DM dx. | No | 28,950 (92.8) | 28,717 (92.8) | 233 (89.2) | 3.911 (0.010) |
Yes | 2948 (7.2) | 2909 (7.2) | 39 (10.8) | ||
Renal failure dx. | No | 30,946 (99.7) | 30,688 (99.7) | 258 (99.2) | 1.329 (0.074) |
Yes | 103 (0.3) | 100 (0.3) | 3 (0.8) |
Characteristics | Variables | Categories | HCV Antibody Positive | ||
---|---|---|---|---|---|
OR | 95% CI | p | |||
Socio- Demographic characteristics | Age | 20s (Ref.) | 1 | <0.001 | |
30s | 0.812 | 0.387–1.704 | |||
40s | 2.189 | 1.179–4.066 | |||
50s | 3.159 | 1.752–5.694 | |||
≥60s | 3.331 | 1.853–5.987 | |||
House income | Low (Ref.) | 1 | 0.294 | ||
Middle | 0.840 | 0.648–1.090 | |||
High | 0.767 | 0.533–1.103 | |||
Education | ≤Elementary (Ref.) | 1 | 0.030 | ||
Middle | 0.826 | 0.584–1.169 | |||
High school | 0.687 | 0.496–0.952 | |||
≥College | 0.592 | 0.410–0.854 | |||
Working status | No (Ref.) | 1 | 0.346 | ||
Yes | 0.901 | 0.726–1.119 | |||
Health behavior and disease characteristics | Self-rated health status | Bad (Ref.) | 1 | <0.001 | |
Moderate | 0.654 | 0.507–0.843 | |||
Good | 0.479 | 0.343–0.670 | |||
Past smoking period (years) | <1 (Ref.) | 1 | 0.433 | ||
1–10 | 0.626 | 0.307–1.275 | |||
≥10 | 0.924 | 0.704–1.212 | |||
CVA dx. | No (Ref.) | 1 | 0.071 | ||
Yes | 1.493 | 0.966–2.308 | |||
Liver cancer dx. | No (Ref.) | 1 | 0.434 | ||
Yes | 1.474 | 0.557–3.905 | |||
Cirrhosis dx. | No (Ref.) | 1 | <0.001 | ||
Yes | 8.661 | 4.641–16.164 | |||
Hepatitis B dx. | No (Ref.) | 1 | 0.864 | ||
Yes | 0.934 | 0.428–2.040 | |||
DM dx. | No (Ref.) | 1 | 0.051 | ||
Yes | 0.704 | 0.495–1.002 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Kim, T.; Kim, J. Factors Associated with Hepatitis C Antibody Positivity in Korean Adults: A Cross-Sectional Study Based on 2013–2018 Korea National Health and Nutrition Examination Survey. Healthcare 2021, 9, 1366. https://doi.org/10.3390/healthcare9101366
Kim T, Kim J. Factors Associated with Hepatitis C Antibody Positivity in Korean Adults: A Cross-Sectional Study Based on 2013–2018 Korea National Health and Nutrition Examination Survey. Healthcare. 2021; 9(10):1366. https://doi.org/10.3390/healthcare9101366
Chicago/Turabian StyleKim, Taehui, and Jiyoung Kim. 2021. "Factors Associated with Hepatitis C Antibody Positivity in Korean Adults: A Cross-Sectional Study Based on 2013–2018 Korea National Health and Nutrition Examination Survey" Healthcare 9, no. 10: 1366. https://doi.org/10.3390/healthcare9101366
APA StyleKim, T., & Kim, J. (2021). Factors Associated with Hepatitis C Antibody Positivity in Korean Adults: A Cross-Sectional Study Based on 2013–2018 Korea National Health and Nutrition Examination Survey. Healthcare, 9(10), 1366. https://doi.org/10.3390/healthcare9101366